Skip to content

Opaleye Management Inc.

Follow

13F filer, CIK 1595855, BOSTON, MA

Opaleye Management Inc. reported $887,720,997 across 58 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 62.58% of the portfolio.

Accepted , ingested 13F-HR 0001420506-26-002880

Period
2026-09-30
Reported value
$888M
Holdings
58
Top 10 weight
62.58%
New
10
Sold out
10

Part of the filer group Opaleye Management Inc.

  • James Silverman
How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SMMTnew+1,051,901$17.8M
IRONadded+240,000$15.7M
BHVNadded+1,112,085$14.8M
HRMYnew+230,000$9.03M
VSTMadded+953,333$7.67M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
APGEexited-390,000-$51.8M
ETONreduced-420,000-$21.6M
XOMAexited-338,374-$14.4M
MBXreduced-240,000-$14.1M
EWTXreduced-325,000-$13.2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001420506-26-002880, largest first. % of portfolio is the value over $887,720,997, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ETONETON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,852,070 shares; 2025Q1: 2,852,070 shares; 2025Q2: 2,860,000 shares; 2025Q3: 2,860,000 shares; 2025Q4: 2,860,000 shares; 2026Q1: 2,860,000 shares; 2026Q2: 2,860,000 shares; 2026Q3: 2,440,000 shares 2,440,000$126M14.15%-420,000Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 85,000 shares; 2025Q2: 186,418 shares; 2025Q3: 193,773 shares; 2025Q4: 200,000 shares; 2026Q1: 421,000 shares; 2026Q2: 855,000 shares; 2026Q3: 1,095,000 shares 1,095,000$71.7M8.07%+240,000Timeline
HROWHARROW INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,990,000 shares; 2025Q1: 3,955,000 shares; 2025Q2: 3,905,000 shares; 2025Q3: 3,905,000 shares; 2025Q4: 3,905,000 shares; 2026Q1: 2,832,230 shares; 2026Q2: 2,400,000 shares; 2026Q3: 2,105,000 shares 2,105,000$64.8M7.3%-295,000Timeline
LQDALIQUIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,698,142 shares; 2025Q1: 2,260,000 shares; 2025Q2: 2,475,000 shares; 2025Q3: 2,615,000 shares; 2025Q4: 2,435,000 shares; 2026Q1: 2,545,000 shares; 2026Q2: 2,447,500 shares; 2026Q3: 2,110,000 shares 2,110,000$63.8M7.19%-337,500Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 220,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 268,423 shares; 2026Q1: 1,430,000 shares; 2026Q2: 1,439,996 shares; 2026Q3: 1,439,996 shares 1,439,996$58.5M6.59%0Timeline
SLGLSOL-GEL TECHNOLOGIES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 204,835 shares; 2025Q4: 453,739 shares; 2026Q1: 500,000 shares; 2026Q2: 500,000 shares; 2026Q3: 555,000 shares 555,000$41.2M4.64%+55,000Timeline
MGTXMEIRAGTX HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 390,844 shares; 2026Q1: 2,123,259 shares; 2026Q2: 3,550,000 shares; 2026Q3: 3,600,000 shares 3,600,000$39.6M4.46%+50,000Timeline
TGTXTG THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,260,000 shares; 2025Q1: 535,000 shares; 2025Q2: 535,000 shares; 2025Q3: 535,000 shares; 2025Q4: 535,000 shares; 2026Q1: 535,000 shares; 2026Q2: 535,000 shares; 2026Q3: 557,000 shares 557,000$31.1M3.5%+22,000Timeline
ACOGALPHA COGNITION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 115,142 shares; 2025Q4: 2,070,784 shares; 2026Q1: 2,561,950 shares; 2026Q2: 2,895,467 shares; 2026Q3: 3,303,904 shares 3,303,904$29.7M3.35%+408,4372026-10-23, Form 4: bought 14,973 shares on 2026-10-23 Timeline
IMMXIMMIX BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,345,000 shares; 2026Q3: 2,825,000 shares 2,825,000$29.4M3.31%+480,000Timeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,178,300 shares; 2026Q1: 1,312,615 shares; 2026Q2: 1,319,351 shares; 2026Q3: 1,645,984 shares 1,645,984$24M2.71%+326,633Timeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,800,000 shares; 2026Q3: 2,753,333 shares 2,753,333$22.2M2.5%+953,333Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 105,000 shares; 2025Q3: 100,000 shares; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000$20.5M2.31%0Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,384,993 shares; 2026Q3: 1,384,993 shares 1,384,993$18.3M2.07%0Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 25,000 shares; 2025Q1: 300,000 shares; 2025Q2: 562,120 shares; 2025Q3: 682,017 shares; 2025Q4: 695,000 shares; 2026Q1: 700,000 shares; 2026Q2: 700,000 shares; 2026Q3: 692,181 shares 692,181$18M2.03%-7,819Timeline
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,051,901 shares 1,051,901$17.8M2%newTimeline
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 465,000 shares; 2025Q1: 465,000 shares; 2025Q2: 903,442 shares; 2025Q3: 903,442 shares; 2025Q4: 6,287,156 shares; 2026Q1: 6,300,000 shares; 2026Q2: 6,300,000 shares; 2026Q3: 4,087,045 shares 4,087,045$16.9M1.91%-2,212,955Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 77,915 shares; 2026Q3: 1,190,000 shares 1,190,000$15.9M1.79%+1,112,085Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 105,000 shares; 2025Q1: 105,000 shares; 2025Q2: 105,000 shares; 2025Q3: 105,000 shares; 2025Q4: 105,000 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000$14.1M1.59%0Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 745,000 shares; 2026Q3: 1,035,000 shares 1,035,000$12.3M1.39%+290,000Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 500,000 shares; 2025Q1: 490,000 shares; 2025Q2: 475,000 shares; 2025Q3: 461,700 shares; 2025Q4: 330,000 shares; 2026Q1: 123,000 shares; 2026Q2: 122,500 shares; 2026Q3: 122,500 shares 122,500$11.7M1.31%0Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 213,363 shares; 2026Q1: 1,256,228 shares; 2026Q2: 931,000 shares; 2026Q3: 1,120,000 shares 1,120,000$9.26M1.04%+189,000Timeline
HRMYHARMONY BIOSCIENCES HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 230,000 shares 230,000$9.03M1.02%newTimeline
EDITEDITAS MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,926,997 shares; 2026Q2: 3,861,930 shares; 2026Q3: 3,486,452 shares 3,486,452$8.96M1.01%-375,478Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 775,000 shares; 2025Q3: 665,000 shares; 2025Q4: 535,000 shares; 2026Q1: 550,000 shares; 2026Q2: 550,000 shares; 2026Q3: 1,001,900 shares 1,001,900$7.4M0.83%+451,900Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 480,000 shares; 2025Q1: 395,000 shares; 2025Q2: 490,000 shares; 2025Q3: 500,000 shares; 2025Q4: 500,000 shares; 2026Q1: 500,000 shares; 2026Q2: 500,000 shares; 2026Q3: 175,000 shares 175,000$7.11M0.8%-325,000Timeline
GRCEGRACE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,798,167 shares 2,798,167$6.02M0.68%new2026-11-18, Form 4: bought 2,974 shares on 2026-11-18 Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 315,171 shares 315,171$5.93M0.67%newTimeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 426,989 shares 426,989$5.06M0.57%newTimeline
ADCTADC THERAPEUTICS SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 682,529 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 700,000 shares; 2026Q3: 4,070,819 shares 4,070,819$4.97M0.56%+3,370,819Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 400,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 280,808 shares 280,808$4.89M0.55%newTimeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 112,291 shares; 2026Q2: 334,437 shares; 2026Q3: 334,437 shares 334,437$4.79M0.54%0Timeline
INBXINHIBRX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 20,291 shares; 2026Q3: 45,500 shares 45,500$4.55M0.51%+25,209Timeline
CABACABALETTA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 808,882 shares; 2025Q4: 900,000 shares; 2026Q1: 1,380,000 shares; 2026Q2: 3,863,800 shares; 2026Q3: 2,321,602 shares 2,321,602$4.46M0.5%-1,542,198Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,317,500 shares; 2025Q1: 795,000 shares; 2025Q2: 390,000 shares; 2025Q3: 390,000 shares; 2025Q4: 345,100 shares; 2026Q1: 345,100 shares; 2026Q2: 310,000 shares; 2026Q3: 310,000 shares 310,000$4.44M0.5%0Timeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,196,904 shares; 2026Q1: 1,150,000 shares; 2026Q2: 1,185,000 shares; 2026Q3: 1,630,000 shares 1,630,000$4.37M0.49%+445,000Timeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,767,500 shares; 2025Q1: 1,985,000 shares; 2025Q2: 1,924,300 shares; 2025Q3: 316,550 shares; 2025Q4: 1,400,906 shares; 2026Q1: 1,412,656 shares; 2026Q2: 1,412,656 shares; 2026Q3: 1,412,656 shares 1,412,656$3.91M0.44%0Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,342,500 shares; 2025Q1: 1,595,000 shares; 2025Q2: 1,595,000 shares; 2025Q3: 1,595,000 shares; 2025Q4: 1,595,000 shares; 2026Q1: 600,000 shares; 2026Q2: 600,000 shares; 2026Q3: 506,436 shares 506,436$3.88M0.44%-93,564Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 935,000 shares; 2026Q1: 935,000 shares; 2026Q2: 935,000 shares; 2026Q3: 1,000,000 shares 1,000,000$3.77M0.42%+65,000Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,600,000 shares; 2025Q4: 2,600,000 shares; 2026Q1: 2,331,761 shares; 2026Q2: 1,714,451 shares; 2026Q3: 875,000 shares 875,000$3.7M0.42%-839,451Timeline
IRDOPUS GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,175,000 shares; 2025Q2: 1,220,000 shares; 2025Q3: 1,100,000 shares; 2025Q4: 1,120,000 shares; 2026Q1: 1,120,000 shares; 2026Q2: 1,125,000 shares; 2026Q3: 750,000 shares 750,000$3.63M0.41%-375,000Timeline
CDXSCODEXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,840,000 shares; 2025Q1: 9,500,000 shares; 2025Q2: 12,600,000 shares; 2025Q3: 12,795,000 shares; 2025Q4: 6,789,738 shares; 2026Q1: 6,785,000 shares; 2026Q2: 6,785,000 shares; 2026Q3: 2,590,000 shares 2,590,000$3.6M0.41%-4,195,000Timeline
BLSMBLOSSOMHILL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 175,000 shares 175,000$3.26M0.37%newTimeline
LYELLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 79,097 shares; 2026Q2: 344,025 shares; 2026Q3: 291,353 shares 291,353$2.85M0.32%-52,672Timeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 955,000 shares; 2026Q1: 955,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000$2.63M0.3%0Timeline
BDSXBIODESIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 238,047 shares; 2026Q2: 180,000 shares; 2026Q3: 87,000 shares 87,000$2.6M0.29%-93,000Timeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 53,282 shares; 2026Q2: 700,000 shares; 2026Q3: 630,000 shares 630,000$2.58M0.29%-70,000Timeline
OKYOOKYO PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 375,204 shares; 2026Q3: 1,620,000 shares 1,620,000$2.09M0.24%+1,244,7962026-11-16, 13G: 5,000,000 shares, 9.53% of the class, 13G filed 2026-11-20 Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 427,608 shares; 2026Q1: 427,608 shares; 2026Q2: 145,000 shares; 2026Q3: 140,463 shares 140,463$1.97M0.22%-4,537Timeline
ENTAENANTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 75,000 shares; 2026Q1: 125,000 shares; 2026Q2: 125,000 shares; 2026Q3: 125,000 shares 125,000$1.65M0.19%0Timeline
FBIOFORTRESS BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,090,000 shares; 2026Q1: 1,042,000 shares; 2026Q2: 890,000 shares; 2026Q3: 720,000 shares 720,000$1.54M0.17%-170,000Timeline
SNWVSANUWAVE HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 972,002 shares; 2025Q2: 980,000 shares; 2025Q3: 980,000 shares; 2025Q4: 981,267 shares; 2026Q1: 981,267 shares; 2026Q2: 306,140 shares; 2026Q3: 306,140 shares 306,140$1.44M0.16%0Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 250,000 shares; 2025Q2: 239,319 shares; 2025Q3: 253,000 shares; 2025Q4: 260,000 shares; 2026Q1: 260,000 shares; 2026Q2: 260,000 shares; 2026Q3: 20,000 shares 20,000$1.17M0.13%-240,000Timeline
OBXOBSIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 75,755 shares 75,755$1.04M0.12%newTimeline
DERMJOURNEY MED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 69,323 shares; 2025Q2: 95,000 shares; 2025Q3: 971,064 shares; 2025Q4: 975,000 shares; 2026Q1: 960,000 shares; 2026Q2: 350,000 shares; 2026Q3: 125,000 shares 125,000$855K0.1%-225,000Timeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 69,348 shares 69,348$687K0.08%newTimeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 70,000 shares 70,000$368K0.04%newTimeline
ADGMADAGIO MED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 110,571 shares; 2025Q1: 110,571 shares; 2025Q2: 110,571 shares; 2025Q3: 110,571 shares; 2025Q4: 18,444 shares; 2026Q1: 18,444 shares; 2026Q2: 18,444 shares; 2026Q3: 18,444 shares 18,444$2.82K<0.01%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
APGEAPOGEE THERAPEUTICS INC390,000$51.8Mshares
XOMAXOMA ROYALTY CORPORATION338,374$14.4Mshares
NTLAINTELLIA THERAPEUTICS INC250,000$4.23Mshares
PHATPHATHOM PHARMACEUTICALS INC185,589$2.01Mshares
COAGHEMAB THERAPEUTICS HLDGS INC47,652$1.75Mshares
TRAXFIRST TRACKS BIOTHERAPEUTICS65,000$1.31Mshares
CGONCG ONCOLOGY INC17,789$1.26Mshares
AVIRATEA PHARMACEUTICALS INC235,000$1.09Mshares
KTTAPASITHEA THERAPEUTICS CORP2,050,000$1.06Mshares
PTNPALATIN TECHNOLOGIES INC20,500$221Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-26-002880 base2026-11-16